JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
158 hedge funds and large institutions have $2.34B invested in Juno Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 52 increasing their positions, 45 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
-2
Holders Change %
-1.25%
% of All Funds
4.22%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
39
Increased
52
Reduced
45
Closed
38
Calls
$46.6M
Puts
$24.6M
Net Calls
+$22.1M
Net Calls Change
+$41.5M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$416M |
| 2 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
$37.8M |
| 3 |
Morgan Stanley
New York
|
$47.8M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
$19.1M |
| 5 |
Millennium Management
New York
|
$9.9M |
Top Sellers
| 1 |
CM
Crestline Management
Fort Worth,
Texas
|
$654M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$217M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
$34.2M |
| 4 |
BAMCO Inc
New York
|
$0 |
| 5 |
Goldman Sachs
New York
|
$4.03M |
